A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects

British Journal of Clinical Pharmacology

Volumn 71, Issue 6, 2011, Pages 852-859

  Brunner, Martin ^a   Davies, David ^b   Martin, Wolfgang ^c   Leuratti, Chiara ^d   Lackner, Edith ^a   Müller, Markus ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Surrey Technology Centre   (United Kingdom)

^c Pharmakin GmbH   (Germany)

^d Cross Research SA   (Switzerland)

Author keywords

Bioavailabilty; Dermal penetration; Diclofenac; Microdialysis; Topical

Indexed keywords

DICLOFENAC; DICLOFENAC DIETHYLAMINE; EUCALYPTUS OIL; MENTHOL;

ADIPOSE TISSUE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; ERYTHEMA; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MICRODIALYSIS; MUSCLE TISSUE; NORMAL HUMAN; PRIORITY JOURNAL; YOUDEN INDEX;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DICLOFENAC; HUMANS; MALE; SKIN ABSORPTION; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 79955817664     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.03914.x     Document Type: Article

References (20)

1. European Medicines Agency. Available at (last accessed 13 July 2010).
2. Zacher J, Altman R, Bellamy N, Brühlmann P, Da Silva J, Huskisson E, Taylor RS. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin 2008; 24: 925-50.
3. Castelnuovo E, Cross P, Mt-Isa S, Spencer A, Underwood M. TOIB study team. Cost-effectiveness of advising the use of topical or oral ibuprofen for knee pain; the TOIB study [ISRCTN: 79353052]. Rheumatology (Oxford) 2008; 47: 1077-81.
4. Barthel HR, Haselwood D, Longley S 3rd, Gold MS, Altman RD. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum 2009; 39: 203-12.
5. Altman RD, Dreiser RL, Fisher CL, Chase WF, Dreher DS, Zacher J. Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol 2009; 36: 1991-9.
6. Cordero JA, Camacho M, Obach R, Domenech J, Vila L. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDS. Eur J Pharm Biopharm 2001; 51: 135-42.
7. Müller M, Rastelli C, Ferri P, Jansen B, Breiteneder H, Eichler HG. Transdermal penetration of diclofenac after multiple epicutaneous administration. J Rheumatol 1998; 25: 1833-6.
8. Müller M, Mascher H, Kikuta C, Schäfer S, Brunner M, Dorner G, Eichler HG. Diclofenac concentrations in defined tissue layers after topical administration. Clin Pharmacol Ther 1997; 62: 293-9.
9. Burian M, Tegeder I, Seegel M, Geisslinger G. Peripheral and central antihyperalgesic effects of diclofenac in a model of human inflammatory pain. Clin Pharmacol Ther 2003; 74: 113-20.
10. Dehghanyar P, Mayer BX, Namiranian K, Mascher H, Müller M, Brunner M. Topical skin penetration of diclofenac after single- and multiple-dose application. Int J Clin Pharmacol Ther 2004; 42: 353-9.
11. Brunner M, Dehghanyar P, Seigfried B, Martin W, Menke G, Müller M. Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation. Br J Clin Pharmacol 2005; 60: 573-7.
12. Kienzler JL, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol 2010; 50: 50-61.
13. Schmidt S, Banks R, Kumar V, Rand KH, Derendorf H. Clinical microdialysis in skin and soft tissues: an update. J Clin Pharmacol 2010; 48: 351-64.
14. Holmgaard R, Nielsen JB, Benfeldt E. Microdialysis sampling for investigations of bioavailability and bioequivalence of topically administered drugs: current state and future perspectives. Skin Pharmacol Physiol 2010; 23: 225-43.
15. Sioufi A, Pommier F, Boschet F, Godbillon J, Lavoignat D, Salliere D. Percutaneous absorption of diclofenac in healthy volunteers after single and repeated topical application of diclofenac Emulgel. Biopharm Drug Dispos 1994; 15: 441-9.
16. Tas C, Ozkan Y, Okyar A, Savaser A. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers. Drug Deliv 2007; 14: 453-9.
17. Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet 1983; 8: 297-331.
18. Miyatake S, Ichiyama H, Kondo E, Yasuda K. Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. Br J Clin Pharmacol 2009; 67: 125-9.
19. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994; 90: 11693-7.
20. Pairet M, Churrchill L, Trummlitz G, Engelhardt G. Diffential inhibition of cyclooxygenase-1 (COX-1) and -2 (COX-2) by NSAIDs: consequences on anti-inflammatory activity versus gastric and renal safety. Inflammopharmacology 1996; 4: 61-70.